Inhibrx Biosciences, Inc.
INBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,688 | -$240 | -$145 | -$82 |
| Dep. & Amort. | $2 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | -$0 |
| Stock-Based Comp. | $59 | $25 | $20 | $15 |
| Change in WC | $52 | $15 | $3 | -$18 |
| Other Non-Cash | -$1,995 | $5 | $5 | $3 |
| Operating Cash Flow | -$194 | -$193 | -$115 | -$80 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$5 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$3 | -$5 | -$1 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $72 | $202 | $130 | $40 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $129 | $84 |
| Financing Cash Flow | $72 | $202 | $259 | $84 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$125 | $4 | $143 | $3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $278 | $274 | $131 | $129 |
| End Cash | $153 | $278 | $274 | $131 |
| Free Cash Flow | -$197 | -$198 | -$116 | -$81 |